CBD stands for cannabidiol, a naturally occurring compound found in the Cannabis sativa plant. In medical terms, it is classified as a phytocannabinoid, meaning it is a cannabinoid produced by a plant rather than by the human body. CBD shares the same chemical formula as THC (the compound in cannabis that causes a high), but a small structural difference means the two substances behave very differently in the body. CBD does not produce intoxication, and the World Health Organization has found no evidence of abuse or dependence potential with pure CBD.
How CBD Differs From THC
THC and CBD are often described as siblings. They have identical atoms arranged in slightly different shapes: THC contains a cyclic ring structure, while CBD contains a hydroxyl group. That single difference changes everything about how each compound interacts with the brain.
THC produces its “high” by directly activating a receptor in the brain called CB1. It binds to this receptor with high potency, triggering the euphoria, altered perception, and impaired coordination associated with cannabis use. CBD, by contrast, binds poorly to that same receptor. Instead of activating CB1, CBD acts as what pharmacologists call a negative allosteric modulator. It essentially changes the shape of the receptor so that both THC and the body’s own cannabis-like molecules have a harder time activating it. This is why CBD can actually reduce some of THC’s effects rather than adding to them.
How CBD Works in the Body
Rather than working through a single receptor the way THC does, CBD influences several different systems at once. It activates pain-sensing channels (called TRPV1 receptors) and then gradually lowers their sensitivity, which may partly explain its anti-inflammatory effects. It also activates serotonin receptors involved in mood regulation, which is thought to be responsible for its calming, anxiety-reducing properties.
Beyond those targets, CBD affects calcium channels that control how excitable nerve cells are, and it interacts with a receptor involved in regulating inflammation throughout the body. The net result is a compound that can dial down inflammatory signaling by increasing anti-inflammatory molecules and decreasing pro-inflammatory ones. This broad, multi-target activity is why researchers have studied CBD for conditions as varied as epilepsy, anxiety, and chronic pain.
FDA-Approved Medical Use
The only CBD medication with full FDA approval is Epidiolex, a purified oral solution used to treat seizures. It is approved for patients 2 years of age and older with two severe forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. Both are rare childhood-onset conditions that often resist standard seizure medications.
In clinical trials for epilepsy, CBD was typically given at around 15 mg per kilogram of body weight per day as an add-on to existing seizure drugs. All 11 epilepsy studies in a large systematic review showed that CBD reduced seizure frequency or severity. For anxiety, much lower doses have been studied. A single 600 mg dose reduced subjective anxiety in a controlled trial of adults with social anxiety disorder, and a case report found that just 25 mg per day helped with anxiety and insomnia related to PTSD. Chronic pain research has used a wide range of doses, though results so far have been less consistent than those for epilepsy.
Absorption and Bioavailability
One of CBD’s biggest practical challenges is that the body absorbs it poorly when swallowed. Oral bioavailability is estimated at roughly 6%, meaning only a small fraction of what you take actually reaches your bloodstream. Peak blood levels after swallowing CBD take 1 to 4 hours to arrive.
Inhaled CBD is absorbed much more efficiently, with bioavailability averaging around 31% and peak blood levels appearing within about 3 minutes. Newer delivery technologies, like self-emulsifying capsules that break CBD into tiny droplets, have improved oral absorption significantly. Some formulations show 30 to 34% higher bioavailability than older sublingual sprays. These differences matter because the route of delivery directly affects how much CBD your body can actually use and how quickly you feel its effects.
Side Effects
CBD is generally well tolerated, but it is not side-effect free, especially at the higher doses used in clinical trials. The most commonly reported side effects across studies include drowsiness, diarrhea, decreased appetite, and fatigue. In epilepsy trials using medical-grade CBD, 86% of treated patients experienced at least one side effect, with diarrhea (19%), drowsiness (14%), decreased appetite (13%), and fever (13%) being the most frequent. A trial in Parkinson’s disease patients reported even higher rates of diarrhea (85%), drowsiness (69%), and fatigue (61%), likely reflecting the older age and vulnerability of that population.
Liver enzyme elevations are a known concern. Some trials have documented increases in liver function markers, particularly when CBD is taken alongside other medications that are processed by the liver. This is because CBD is extensively metabolized by the liver’s cytochrome P450 enzyme system and also inhibits many of those same enzymes. That dual role means CBD can change how quickly your body breaks down other medications, raising or lowering their blood levels in unpredictable ways. This is especially relevant for people taking anti-seizure drugs, blood thinners, or other medications with narrow dosing windows.
Legal and Safety Classification
The World Health Organization conducted a critical review of CBD and concluded that pure CBD shows no effects indicative of abuse or dependence potential in either animal models or human studies. No cases of recreational misuse of pure CBD have been reported, and no public health problems such as impaired-driving incidents have been associated with its use. This assessment applies specifically to pure CBD, not to cannabis products that may contain varying amounts of THC alongside CBD.
In the United States, CBD derived from hemp (cannabis containing less than 0.3% THC) was federally legalized in 2018, though state laws vary. The FDA has warned that many commercially available CBD products are inconsistently labeled, with some containing more or less CBD than stated and others containing detectable levels of THC. Prescription CBD (Epidiolex) is the only form subject to the rigorous quality and dosing standards applied to pharmaceutical drugs.